PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trialFlorian Lordick, J. R. Siewert, Sylvie Lorenzen et al.|The Lancet Oncology|2007Cited by 808
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometryMichal Bassani‐Sternberg, Angela M. Krackhardt, Eva Bräunlein et al.|Nature Communications|2016Cited by 727
Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV MelanomaAxel Hauschild, Ulrich Keilholz, Sanjiv S. Agarwala et al.|Journal of Clinical Oncology|2009Cited by 545